The diagnosis and management of patients with giant cell arteritis

Journal of Rheumatology

Volumn 32, Issue 7, 2005, Pages 1186-1188

  Gonzalez Gay, Miguel A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE;

CLINICAL FEATURE; EARLY DIAGNOSIS; EDITORIAL; ERYTHROCYTE SEDIMENTATION RATE; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; STEROID THERAPY;

ADRENAL CORTEX HORMONES; HUMANS; TEMPORAL ARTERITIS;

EID: 22244455717     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001;27:729-49.
2. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol 2002;14:3-10.
3. Drehmer TJ, Khanna D, Markert RJ, Hawkins RA. Diagnostic and management trends of giant cell arteritis: A physician survey. J Rheumatol 2005;32:1283-9.
4. Hall S, Hunder GG. Is temporal artery biopsy prudent? Mayo Clin Proc 1984;59:793-6.
5. Allsop CJ, Gallagher PJ. Temporal artery biopsy in giant-cell arteritis. A reappraisal. Am J Surg Pathol 1981;5:317-23.
6. Hall S, Persellin S, Lie JT, O'Brien PC, Kurland LT, Hunder GG. The therapeutic impact of temporal artery biopsy. Lancet 1983;2:1217-20.
7. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001;30:249-56.
8. Stone JH, Calabrese LH, Hoffman GS, Pusey CD, Hunder GG, Hellmann DB. Vasculitis. A collection of pearls and myths. Rheum Dis Clin North Am 2001;27:677-728.
9. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J. Giant cell arteritis without clinically evident vascular involvement in a defined population. Arthritis Rheum 2004;51:274-7.
10. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: Disease patterns of clinical presentation in a series of 240 patients. Medicine Baltimore 2005; (in press).
11. Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez-Ledo P, Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 2001;60:367-71.
12. Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 2001;45:140-5.
13. Elliot DL, Watts WJ, Reuler JB. Management of suspected temporal arteritis. A decision analysis. Med Decis Making 1983;3:63-8.
14. Achkar AA, Lie JT, Hunder GG, O'Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120:987-92.
15. Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc 1976;51:504-10.
16. Kent RB 3rd, Thomas L. Temporal artery biopsy. Am Surg 1990;56:16-21.
17. Taylor-Gjevre R, Vo M, Shukla D, Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol 2005;32:1279-82.
18. Ponge T, Barrier JH, Grolleau JY, Ponge A, Vlasak AM, Cottin S. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol 1988;15:997-1000.
19. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.
20. Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med 1975;82:613-8.